Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible for Standard Treatment

NCT07275216 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Classic Hodgkin Lymphoma

Interventions

PROCEDURE: Biospecimen Collection
DRUG: Brentuximab Vedotin
PROCEDURE: Computed Tomography
DRUG: Dacarbazine
PROCEDURE: Echocardiography Test
DRUG: Gemcitabine
BIOLOGICAL: Pembrolizumab
OTHER: Physical Performance Testing
PROCEDURE: Positron Emission Tomography
PROCEDURE: Pulmonary Function Test

Sponsor

City of Hope Medical Center

Collaborators

[object Object]